Connect with us

Politics

Congressional Lawmakers Have Little To Say About Decriminalizing Psychedelics Following Denver Victory

Published

on

Last week, Denver voters approved an initiative to decriminalize the use, possession and production of psilocybin—the active ingredient in “magic mushrooms” or “shrooms.” And while they are the first in the nation to do so, other states like Oregon and California are also considering putting ballot measures on psychedelics up for a vote in 2020.

But as states are beginning to move toward psilocybin decriminalization, don’t expect the issue to garner the same level of attention in Washington, D.C. that cannabis is currently enjoying—at least not yet. Legislators on Capitol Hill who either come from a state considering psychedelics legislation or have a history of championing marijuana reform—another federal Schedule I substance—had no comment on the issue when asked over the past week.

Sen. Rand Paul (R-KY), a longtime supporter of cannabis reform legislation, was willing to answer questions about what it will take for a marijuana banking bill to pass the Senate, but when asked by Marijuana Moment if states’ rights apply to psilocybin, the senator demurred.

“I don’t, I don’t have a comment on that,” he said, picking up his pace and hurrying down the hall in Dirksen Senate Office Building.

Rep. Diana DeGette (D-CO), who represents Denver, has filed several bills aimed at protecting state cannabis laws from federal intervention following Colorado voters’ approval of legalization in 2012. But her office did not respond to several queries about how the congresswoman voted on the local psilocybin ballot measure last week or what actions she is prepared to take to support it at the federal level.

Meanwhile, Sen. Ron Wyden (D-OR), whose state may put a psilocybin measure on the ballot in 2020, was somewhat aware of the issue but said his office hasn’t considered it deeply.

“As you know, there have been a host of areas where, when the federal government has dragged its feet, the states have moved,” Wyden said.

The senator then directed Marijuana Moment to a health policy aide, who in turn referred to another staffer in the senator’s office who handles cannabis issues, who ultimately said it was an issue they haven’t looked into.

Sen. Jeff Merkley (D-OR) and Reps. Lou Correa (D-CA), Ed Perlmutter (D-CO) and Conor Lamb (D-PA), who have all introduced or cosponsored cannabis legislation, and most of whom come from states considering psilocybin reform, all said they did not know enough about the issue to comment.

Lamb, who has signed onto bills calling for more research into cannabis’s potential medical benefits for military veterans, admitted he didn’t know what psilocybin was.

And Correa, who is the chief sponsor of the same veterans legislation, said, “I don’t know what a mushroom looks like—if it’s big, tall or what.”

Activists in Correa’s home state of California are preparing to place a psilocybin decriminalization measure on the state’s general election ballot next year.

The reluctant response isn’t surprising to advocates. Jag Davies of the Drug Policy Alliance, a group that advocates for the decriminalization of all drugs, including marijuana and psilocybin, says that cannabis is by far the most well-known Schedule I substance among politicians.

“That shows right there how different [psilocybin] is from marijuana, where it isn’t… a name people are familiar with,” says Davies.

And many D.C.-based cannabis advocacy groups also do not have plans to incorporate mushrooms into their daily lobbying agenda.

“We have marijuana on the door, not drug,” Justin Strekal of NORML told Marijuana Moment.

Part of the reason for this, especially among advocates, is the impact level. Exponentially more Americans are arrested every year for cannabis possession than for mushrooms. According to the Denver district attorney’s office, only 11 psilocybin cases went to trial there over the past three years. Conversely, in Colorado the year before marijuana became legal, more than 12,000 people were arrested on cannabis-related charges.

Davies says singling out specific, smaller-impact drugs like psilocybin is a mistake that results in the lack of attention given to the issue on the federal level. Advocates feel that instead of trying to tackle the issue piecemeal, states and municipalities trying to end drug prohibition should take a holistic view of decriminalization, as the Colorado legislature has done in passing a bill that decriminalizes single possession of a Schedule I or Schedule II drug—which includes psilocybin. That bill is now headed to the Gov. Jared Polis (D), who is expected to sign it.

Most advocates agree, though, that psilocybin likely would not have been decriminalized had cannabis not already paved the way. And even so, it wasn’t until multiple states legalized marijuana for recreational use that Congress began to take cannabis legislation seriously. When Barack Obama ran for president in 2008, for example, his campaign took pains to clarify that he didn’t even support decriminalizing cannabis; but in 2019, Democratic presidential hopefuls are practically tripping over each other to show greater support for legalizing marijuana outright.

For most politicians on Capitol Hill, cannabis is where their focus is going to stay for the foreseeable future.

“We’ve spent years setting the table for the blueprint, dealing with cannabis legalization,” says long-time cannabis advocate Rep. Earl Blumenauer (D-OR), who released a ‘blueprint’ detailing the path toward comprehensive cannabis legalization on the federal level last year.

“I’m resisting the siren call of being involved with each thing that comes down the path,” he said when Marijuana Moment asked whether he would endorse the proposed psilocybin measure that could appear on the ballot in his home state of Oregon next year.

But even while there appear to be no members of Congress who are currently ready to actively champion broader drug policy reform concerning psychedelics, some are keeping an open mind on the issue.

“Let me tell you how I came to the conclusion that veterans needed to be treated with cannabis: they came to me,” said Correa, who has since led the charge to expand veterans-focused marijuana research.

“I think [also considering psilocybin research for veterans] is a possibility,” the congressman added. “I think we need to look at other alternatives to treating patients, to treating veterans, other than opioids.”

Denver Psilocybin Decriminalization Activist Pushes Back Against Michael Pollan’s Criticism

Photo courtesy of Wikimedia/Mushroom Observer.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Natalie Fertig is a freelance journalist in Washington, D.C. covering cannabis policy. She hails originally from the Pacific Northwest and is a graduate of CUNY Newmark J-School.

Politics

DC Activists Have A New Plan To Get Psychedelics Decriminalization On The Ballot Despite Coronavirus

Published

on

Activists in Washington, D.C. are considering a new strategy to get a measure to decriminalize psychedelics on the November ballot, with the coronavirus outbreak having forced them to suspend in-person signature gathering.

While Decriminalize Nature D.C. hoped that officials would pass emergency legislation allowing the digital collection of signatures, they aren’t actively considering that option. And the District Council’s chairman said he would not simply place the initiative on the ballot for voters to decide regardless of the signature count.

That’s left the group in a challenging position. But they’re not out of ideas yet.

Now the campaign is exploring the possibility of conducting “micro-scale petition signature collection” to make the ballot. The plan would involve having petitions mailed to supporters, who would circulate it and collect signatures from “registered DC voters in their immediate vicinity, such as family, roommates, friends and close-by neighbors” and then return the signed petitions to the campaign headquarters.

They’ve launched an online survey to determine the feasibility of the option. It asks prospective volunteers to estimate how many signatures they could theoretically collect under that limited scope and provide their mailing information should the campaign decide to move forward with the plan.

This is one of the last remaining options for the 2020 effort, which is working to make a wide range of psychedelics among the district’s lowest law enforcement priorities.

Council Chairman Phil Mendelson (D) said during a press conference on Friday that he “would not say that we’re looking for legislative action to put [the initiative] on the ballot” outside of the conventional process.

Board of Elections Chairman Michael Bennett also took a question about the prospect of allow electronic signature collection. He said his panel is not considering the possibility “at this point.”

Watch the comments below, starting around 22:15:

Decriminalize Nature D.C. is one of numerous groups working to change local and state drug policy laws. And it’s not alone in its struggle amid the current pandemic.

A California campaign to legalize psilocybin mushrooms is struggling and asking for electronic signature gathering to qualify for the ballot.

In Oregon, advocates for a measure to decriminalize drug possession and a separate initiative to legalize psilocybin for therapeutic purposes have suspended in-person campaign events amid the pandemic.

Activists in California recently released a video asking California officials to allow digital signatures for a petition to revise the state’s adult-use marijuana program. An effort to legalize medical cannabis in Nebraska is facing similar signature gathering challenges. A campaign to legalize cannabis in Missouri is also in jeopardy.

Arizona activists shared some more positive news last week, however, announcing that they have collected more than enough signatures to qualify for the state’s November ballot—though they have not yet been submitted to or verified by the state.

Marijuana Legalization Left Out Of New York Budget, According To Draft Summary Document

Photo elements courtesy of carlosemmaskype and Apollo.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Marijuana Legalization Left Out Of New York Budget, According To Draft Summary Document

Published

on

The New York legislature seems poised to eliminate a proposal to legalize marijuana through the budget this year, according to an unverified document outlining the policies included in the spending legislation currently under final negotiations ahead of a vote this week.

The draft budget report, which was shared with Marijuana Moment, includes a line stating that the “Adopted Budget omits the Executive proposal to legalize adult use cannabis.”

It also “eliminates $34.31 million in funding for the Office for Cannabis Management,” a government body that would have been responsible for regulating the marijuana market.

The apparent exclusion of Gov. Andrew Cuomo’s (D) legalization proposal, while disappointing to reform advocates, is not entirely surprising in the context of the coronavirus outbreak. While the governor repeatedly stressed that the policy change should be enacted through the budget, he and top lawmakers have tried to temper expectations in recent weeks as legislative priorities have shifted during the pandemic.

But to some, the draft adopted budget report isn’t necessarily a death knell for the reform move, and they hope lawmakers can still accomplish legalization this year through separate legislation.

“We are disappointed adult use is not in the budget since it would have been a huge economic benefit to New York farmers and small businesses,” Allan Gandelman, president of the NY Cannabis Growers & Processors Association, told Marijuana Moment. “We hope to continue working with the governor and the legislature to get this done as soon as possible.”

The legislature must still vote on the final budget, but there’s little time left to hash out a deal on comprehensive reform ahead of a Wednesday deadline. Sen. Liz Krueger (D) filed a revised standalone legalization bill earlier this month, language of which could have theoretically been inserted into the budget, but it’s not clear that option remains on the table.

Marijuana Moment reached out to Senate and Assembly leadership for comment about the draft budget summary, but representatives were not immediately available. The document, which according to its metadata was last modified on Sunday afternoon, contains highlighted sections for issues that are “still open” for negotiation, but that is not the case for the cannabis items.

This is the second year in a row that Cuomo has pitched legalization as part of his spending plan. Last year, months of negotiation between his office and lawmakers failed to produce a passable bill—with disagreements centering on issues such as how tax revenue would be allocated—and so the effort carried over to this year.

The governor seemed confident that 2020 would be the year for legal cannabis in New York, and he included the proposal in his State of the State address in January. As recently as last week, he indicated the effort was still alive, though he also recognized that it may prove too complicated an issue to ultimately deliver through the budget this round.

“We will pass a budget and address the policy items that we laid out and we discussed because it’s not just about passing a budget and the numbers,” he said. “There are many policy initiatives that I laid out back in January, and we’re going to pursue all of them.”

“The only caveat was if you have a really complex issue that normally would require weeks of nuanced, detailed negotiation to do it right, that we won’t do. Because I don’t want to pass any bills that are not really intelligent that I then have to come back and deal with again next year,” he continued. “If it’s a highly complex issue, I get it and then let’s put it off because we don’t want to do something sloppy.”

Another part of the governor’s legalization plan originally involved visiting legal cannabis states to learn from their experiences and take lessons back home. However, Cuomo said that trip was also impacted by the COVID-19 outbreak.

Meanwhile, drug policy reform efforts across the country are struggling amid the pandemic.

Activists in California recently released a video asking California officials to allow digital signatures for a petition to revise the state’s adult-use marijuana program. In Washington, D.C., advocates for a measure to decriminalize psychedelics similarly wrote to the mayor and local lawmakers, imploring them to accept online signatures for their ballot petition.

Another California campaign to legalize psilocybin mushrooms is struggling and asking for electronic signature gathering to qualify for the ballot. An effort to legalize medical cannabis in Nebraska is facing similar signature gathering challenges. A campaign to legalize cannabis in Missouri is also in jeopardy.

In Oregon, advocates for a measure to decriminalize drug possession and a separate initiative to legalize psilocybin for therapeutic purposes have suspended in-person campaign events amid the pandemic.

Arizona activists shared some more positive news last week, however, announcing that they have collected more than enough signatures to qualify for the state’s November ballot—though they have not yet been submitted to or verified by the state.

Senate Housing Bill Would Prevent Evictions For State-Legal Marijuana Extraction

Photo courtesy of Philip Steffan.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Senate Housing Bill Would Prevent Evictions For State-Legal Marijuana Extraction

Published

on

A new congressional bill designed to promote affordable housing in the U.S. includes a provision that would prevent landlords from evicting people over manufacturing marijuana extracts if they have a license to do so.

Under the legislation, filed earlier this month by Sen. Jeff Merkley (D-OR), there’s a list of “just causes for eviction” such as failure to pay rent or causing significant damage to a property.

The “manufacture of a cannabinoid extract” is another cause for eviction, “unless the tenant holds a license to manufacture the cannabinoid extract under Federal, State, or Tribal law.”

Curiously, however, the bill lacks any additional protections for other state-legal cannabis activities, including simple possession. It’s possible that a drafting error is to blame, but Merkley’s office did not respond to Marijuana Moment’s request for comment.

Just above the manufacturing provision is another that states that “the unlawful manufacture, delivery, or possession of a controlled substance” is ground for eviction, though it contains no caveat exempting state-legal activity as cause for eviction.

Despite the growing number of states moving to allow cannabis for medical or recreational use, it remains “unlawful” under the federal Controlled Substances Act.

While advocates would likely applaud the inclusion of state-legal protection language, it’s also the case that eviction proceedings are handled at the state level, and so some courts would presumably defer to state law when it comes to cannabis-related eviction cases.

Also, when it comes to the manufacturing provision, states generally do not provide licenses that would specifically allow individuals to produce marijuana extracts in their residences, so it’s unclear how impactful that policy would be in practice if enacted into law.

Of course, the cannabis provision is just one notable part of a comprehensive housing bill, which aims to “address the shortcomings of our current housing policies and funding levels by holistically addressing disparities and systematic obstacles and ensuring an equitable outcome for the most vulnerable Americans.”

Rep. Alexandria Ocasio-Cortez (D-NY) and Sen. Kamala Harris (D-CA) rolled out a different kind of housing reform bill last year that would protect people with low-level drug convictions from being denied access to or being evicted from public housing.

Letting VA Doctors Recommend Medical Marijuana To Veterans Won’t Cost Anything, Congressional Analysts Say

Photo courtesy of Mike Latimer.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading
Advertisement

Marijuana News In Your Inbox

Support Marijuana Moment

Marijuana News In Your Inbox

Do NOT follow this link or you will be banned from the site!